Cerivastatin-related fetal rhabdomyolysis;Rhabdomyolyse fatale sous cérivastatine

Revue Medicale de Liege

Volumn 56, Issue 8, 2001, Pages 592-594

  Scheen, A J ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Cholesterol; Combined therapy; Fibrate; Rhabdomyolysis; Side effect; Statin

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; CERIVASTATIN; CHOLSTAT; FENOFIBRATE; FLUINDOSTATIN; GEMFIBROZIL; PRAVASTATIN; SIMVASTATIN;

CAUSE OF DEATH; HUMAN; HYPERLIPIDEMIA; RHABDOMYOLYSIS; RISK BENEFIT ANALYSIS; SHORT SURVEY; UNITED STATES;

HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PYRIDINES; RHABDOMYOLYSIS;

EID: 18744436783     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (18)

1. Le risque cardio-vasculaire lié à l'hyper cholestéolémie: D'un continuum à la notion de normalité, de seuil d'intervention et d'objectif thérapeutique
2. Les recommandations du Belgian Lipid Club pour le diagnostic et le traitement des hyperlipidémies: Résumé pour le praticien
3. Traitement de l'hyperlipidémie combinée: Fibrate ou/et statine?
4. Le traitement des hyperlipidémies
5. Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage
6. Tolerability and efficacy of combination therapy with simvastatin plus gemfibrozil in type IIb refractory familial combined hyperlipidemia
7. Dual bezafibrate-simvastatin therapy for combined hyperlipidemia
8. Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia
9. Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia
10. Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM: A multicenter comparison study
11. Fibrates and statins in the treatment of hyperlipidaemia: An appraisal of their efficacy and safety
12. Le médicament du mois. La cérivastatine (Lipobay®, Cholstat®)
13. Cerivastatin
14. Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia
15. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
16. Etude clinique du mois. Intérêt d'augmenter un taux de cholesterol HDL bas en prévention secondaire de la coronaropathie: Résultats de l'étude VA-HIT
17. Aggressive lipid therapy in the statin era
18. Cholesterol reduction yields clinical benefit: Impact of statin trials